BD completes new syringe and needle manufacturing lines in Nebraska

BD completed new syringe and needle manufacturing lines in Holdrege, Nebraska, as part of a $70 million capital project with $42 million investment from BARDA. The expansion increases domestic capacity for safety injection devices to support U.S. vaccination efforts.

“The new lines increase capacity of BD's existing needle and syringe supply capabilities domestically.”news.bd.com

• 1 source
• news.bd.comBD Unveils Nebraska-Based Manufacturing Capacity to Support U.S. Vaccination Agility and Preparedness - Oct 7, 2021Oct 7, 2021

Summarized from public sources; check the original articles before acting on it.